"ASCO 2026: Interim data released for upcoming BRAF and RAS mCRC therapies" was originally created and published by Clinical ...
MedPage Today on MSN
Targeted Combo Boosts PFS in BRAF-Mutant Metastatic Colorectal Cancer
Adding encorafenib and cetuximab to chemotherapy backbone also prolonged overall survival ...
TransCode Therapeutics, Inc. (NASDAQ:RNAZ) announced Wednesday that it has successfully completed the Phase 1a ...
Pfizer (NYSE:PFE) reported breakthrough Phase 3 results for its BRAFTOVI combination in first-line metastatic colorectal ...
Colorectal cancer is one of the most common types of tumor and is responsible for around 10% of cancer-related deaths worldwide. The tumor is particularly dangerous when it forms metastases—i.e.
The Healthy @Reader's Digest on MSN
5 signs of colon cancer every woman should know
Colon cancer symptoms in women are similar to those in men, but they can be confused with gynecological issues, like cramping ...
Metastatic progression reduction is associated with GLP-1 RA initiation after cancer diagnosis across multiple solid tumors.
India Currents on MSN
Coping with colorectal cancer
Dr. Manoj Sharma, a Professor of Social and Behavioral Health and Internal Medicine and President of Health for All, Inc., ...
A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results